• 1
    Taylor HC Jr. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet. 1929; 48: 702712.
  • 2
    International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scan. 1971; 50: 17.
  • 3
    Serov SF, Scully RE, Sobin LH. Histologic typing of ovarian tumors. In: World Health Organization. International histological classification and staging of tumors: no. 9. Geneva: World Health Organization, 1973.
  • 4
    Mink P, Sherman ME, Devesa S. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States: results from the SEER program, 1978–1997. Cancer. 2002; 95: 23802389.
  • 5
    Lee KR, Scully RE. Mucinous tumors of the ovary. A clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with “pseudomyxoma peritonei.” Am J Surg Pathol. 2000; 24: 14471464.
  • 6
    Rodriguez IM, Prat J. Mucinous tumors of the ovary. A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 2002; 26: 139152.
  • 7
    Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000; 31: 539557.
  • 8
    Silva EG, Kurman RJ, Russell P, Scully RE. Symposium: ovarian tumors of borderline malignancy. Int J Gynecol Pathol. 1996; 15: 281302.
  • 9
    Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001; 19: 26582664.
  • 10
    Scully RE, Young RH, Clement PB. Surface epithelial-stromal tumors, serous tumors. In: Atlas of tumor pathology.Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Fascicle 23, third series. Bethesda: Armed Forces Institute of Pathology, 1998: 5179.
  • 11
    Scully RE, Young RH, Clement PB. Mucinous tumors and pseudomyxoma peritonei. In: Atlas of tumor pathology. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Fascicle 23, third series. Bethesda: Armed Forces Institute of Pathology, 1998: 81105.
  • 12
    Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: KurmanRJ, editor. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 2002: 791904.
  • 13
    Prat J, de Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with invasion. Am J Surg Pathol. 2002; 26: 11111128.
  • 14
    Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996; 20: 13191330.
  • 15
    Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. Am J Surg Pathol. 1996; 20: 13311345.
  • 16
    Eichorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns. A study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999; 23: 397409.
  • 17
    Goldstein NS, Ceniza N. Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients. Am J Clin Pathol. 2000; 114: 380386.
  • 18
    Gershenson DM. Is micropapillary serous carcinoma for real? Cancer. 2002; 95: 677680.
  • 19
    Kempson RL, Hendrickson MR. Ovarian serous borderline tumors: the citadel defended. Hum Pathol. 2000; 31: 525526.
  • 20
    Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol. 1994; 18: 591603.
  • 21
    Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol. 1995; 26: 509524.
  • 22
    Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003; 27: 281292.
  • 23
    Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003; 27: 985993.
  • 24
    Trimble CL, Kosary C, Trimble EL. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 2002; 86: 3437.
  • 25
    RiesLA, EisnerMP, KosaryCL, et al., editors. SEER cancer statistics review, 1973–2000. Bethesda: National Cancer Institute, 2003.
  • 26
    PercyC, Van HoltenV, MuirC, editors. International classification of diseases for oncology (2nd edition). Geneva: World Health Organization, 1990.
  • 27
    National Cancer Institute. SEER*Stat [software online]. Available from URL:[accessed 2003].
  • 28
    Massi D, Susini T, Savino L, Boddi V, Amunni G, Colafranceschi M. Epithelial ovarian tumors in the reproductive age group. Age is not an independent prognostic factor. Cancer. 1996; 77: 11311136.
  • 29
    Diebold J, Seemuller F, Lohrs U. K-ras mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy. Lab Invest. 2003; 83: 251258.
  • 30
    Gu J, Roth LM, Younger C, et al. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. J Natl Cancer Inst. 2001; 93: 11471152.
  • 31
    Lu KH, Bell DA, Welch WR, Berkowitz RS, Mok SC. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998; 58: 23282330.
  • 32
    Ortiz BH, Ailawadi M, Colitti C, et al. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001; 61: 72647267.
  • 33
    Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003; 162: 10951101.
  • 34
    Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 12041211.
  • 35
    Riman T, Dickman PW, Nilsson S, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol. 2001; 83: 575585.
  • 36
    Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer. 1988; 62: 22122222.
  • 37
    Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001; 25: 419432.
  • 38
    Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000; 19: 715.
  • 39
    Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in Stage I invasive epithelial ovarian carcinoma. Lancet. 2001; 357: 176182.
  • 40
    Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002; 359: 572577.
  • 41
    Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with Stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002; 87: 17.
  • 42
    Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB. Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol. 2000; 95: 255260.
  • 43
    Purdie DM, Siskind V, Bain CJ, Webb PM, Green AC. Reproduction-related risk factors for mucinous and non-mucinous epithelial ovarian cancer. Am J Epidemiol. 2001; 153: 860864.
  • 44
    Risch HA, Marrett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol. 1996; 144: 363372.
  • 45
    Schiffman MH, Hartge P, Hoover RN, McGowan L, Lesher L, Norris HJ. Epithelial ovarian cancer. Gynecol Oncol. 1989; 33: 129132.
  • 46
    Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control. 2001; 12: 713719.
  • 47
    Modungo F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology. 2002; 13: 467471.